GT Biopharma, Inc. - GTBP

All tracked SEC files for this issuer. Showing up to 200 latest records.
Need parsed ownership details (13D/13G with shares/percent)? Open ownership details
Form 4 = insider transactions report. Form 144 = notice of proposed sale (not a completed trade confirmation).

Files summary

Total files loaded: 8
Latest filed: Sep 25, 2026
Form Count
8-K 7
SCHEDULE 13G 1

Latest files

Filed Form Report period Accession SEC
Sep 25, 2026 8-K Sep 22, 2026 0001493152-26-044309 View
Sep 21, 2026 8-K Sep 18, 2026 0001493152-26-043562 View
Sep 15, 2026 SCHEDULE 13G — 0001213900-26-100247 View
Sep 15, 2026 8-K Sep 14, 2026 0001493152-26-042672 View
Sep 03, 2026 8-K Sep 02, 2026 0001493152-26-041333 View
Aug 14, 2026 8-K Aug 14, 2026 0001493152-26-038446 View
Jun 12, 2026 8-K Jun 08, 2026 0001493152-26-028457 View
May 22, 2026 8-K May 20, 2026 0001493152-26-024913 View